90 matches.
Biden’s Final Labor Moves
Health Policy Update: Impact of the 2024 U.S. Elections-
Spilling Secrets: Beyond Non-Competes - IP and Trade Secret Assessment Strategies for Employers
-
What a Trump Win Means for Unions
-
How to Navigate Employee Stress After Election Day
-
Advancements of Artificial Intelligence in Health Care – One Year After White House Executive Order
-
Spilling Secrets: Wizarding and the World of Trade Secrets
-
Mental Health Parity Rules, NLRB Restrictions, New York's Workplace Violence Prevention Law
-
NLRB’s Expanding Power—Pushback and Legal Challenges Ahead
-
FTC Exits Labor Pact, EEOC Alleges Significant Underrepresentation in Tech, Sixth Circuit Affirms NLRB Ruling
-
New DOL Guidance: ERISA Plan Cybersecurity Update
New State Legislation Increases Oversight of Health Care Transactions-
DOL Authority Challenged: Key Rulings on Overtime and Tip Credit
-
New HIPAA Final Rule: Key Changes to Reproductive Health Care Privacy
-
Spilling Secrets: After the Block - What’s Next for Employers and Non-Competes?
-
Staples Sued Over MA’s Lie Detector Notice, NJ’s Gender-Neutral Dress Code, 2024 Voting Leave Policies
-
What the FTC Non-Compete Ban Block Means for Employers
-
State Legal Trends: Crucial Changes for Employers
-
Spilling Secrets: What Is the Future of Non-Compete Agreements for Employers?
-
The DEA Is Knocking at Your Door . . . Are You Prepared?
-
SpaceX Victory: Court Questions NLRB's Constitutional Authority
-
The Future of Laboratory Testing Just Got a Little Clearer: FDA's Final Rule on LDTs
-
Spilling Secrets: Can FTC’s Non-Compete Ban Survive Without Chevron Deference?
-
Down Goes Chevron: A 40-Year Precedent Overturned by the Supreme Court
-
Chevron Deference Overturned
-
California Governor’s PAGA Deal: What Employers Need to Know
-
Spilling Secrets: Protecting Trade Secrets with E-Discovery
-
If Cannabis Is Reclassified, What Will Happen to the Marketplace?
-
SCOTUS Limits Availability of Injunctions in NLRB Unfair Labor Practice Cases
-
Key SCOTUS Decisions This Term for Employers
-
EEO-1 Filing After June 4: What to Do Now, and How to Prepare for Next Year
-
Non-Disparagement Settlements in New Jersey, DOL's AI Guidelines, OSHA Regions Shift
-
Unveiling Gender-Affirming Care: Why It Matters and What’s at Stake
-
DOL’s Expanded Overtime Salary Limits, EEOC’s Sexual Harassment Guidance, NY’s Mandatory Paid Prenatal Leave
Litigating Nutrition: Class Action Battles Over Dietary Supplements-
FDA Releases Laboratory-Developed Tests Final Rule
-
Spilling Secrets: FTC Nixes Non-Competes Nationwide—Now What?
-
Avoiding Legal Illusions: Crafting Effective Arbitration Agreements
-
SCOTUS Expands Title VII, EEOC’s Final PWFA Rule, AI Screening Tools
-
Union Reps at OSHA Inspections, New COVID-19 Guidance, and Minimum Wage Updates
-
New DOL Rules, U.S. Government Changes Race and Ethnicity Categorization
-
How Can Employers Prepare for the Future of Pay Equity?
-
“They Said What?! I’ll Sue!” – Litigating Defamatory Claims
-
Braidwood v. Becerra: Challenging the Affordable Care Act’s Preventive Services Coverage Provision
-
Privacy Officer's Roadmap: Data Breach and Ransomware Defense
-
What to Do If the Government Knocks on Your Company’s Door … or Breaks It Down
-
Dietary Supplements: Navigating the Regulatory Maze
-
Game-Changing IRA: Revolutionizing Prescription Drug Pricing and Medicare Benefits
-
Direct Access Laboratory Testing: Future FDA Proposed Regulations on LDTs
-
Inflation Reduction Act’s Drug Price Negotiation Provisions – What Now?
-
Post-Dobbs: One Year Later
-
NLRB Unfair Labor Practice Charges Surge, NYC Prohibits Size Discrimination, FL Expands E-Verify Requirements
-
Managing Trade Secrets and Restrictive Covenants in Health Care M&A Deals
-
What the End of the COVID-19 Public Health Emergency Means for Employers
-
The Legal Battle Over Mifepristone
-
Inflation Reduction Act’s Drug Price Negotiation Provisions – What’s Next?
-
Direct Access Laboratory Testing: Physician Orders and Specimen Collection
-
Legal and Regulatory Landscape for Psychedelics as Therapies
-
Direct Access Laboratory Testing: Reimbursement & Compliance
-
Direct Access Laboratory Testing: Navigating the Regulatory Landscape
-
Unpacking FDA's Final Clinical Decision Support Guidance
-
Post-Dobbs: Considerations for Clinical Trials and Research
-
2023 Health Policy Outlook
-
Post-Dobbs: Access to Reproductive Health Care and Abortion-Inducing Drugs
-
Health Care's Past, Present, and Future
-
Hot Areas in COVID-19 Enforcement, Testing, and Funding
-
Impact of COVID-19 on Pharmacist Scope of Practice: Before and After the PREP Act
-
Entrepreneurship in Biotech: Growing Your Business
-
DOJ Goes After Civil Cyber-Fraud
-
NLRB Outlook, NY Whistleblower Protections Take Effect, DOJ to Focus on Cyber-Fraud
-
SCOTUS Decides on Vaccine Rules, Companies Can Still Require Vaccination, Restrictive Covenants in CO
-
Year in Review and a Look Ahead to 2022
-
Remote Work and Reasonable Accommodations, Important Dates for Federal Contractors, Learn About AI
-
Is the Dietary Supplement Regulatory Framework Working?
Career Pathways: Welcome to Epstein Becker Green – Columbus Ohio Team-
Biden’s Employer Vaccine Mandate, NY HERO Act Safety Plans, Cannabis Cases
-
Biden Touts Employer-Mandated Vaccines, Booster Shot Questions, and EEO-1 Deadline Delayed
-
How Can Companies in the Health Care and Life Sciences Industries Strengthen Their Cybersecurity Posture?
-
Federal and State Cannabis Rules Are Moving in Different Directions
-
President Biden’s Use of the Defense Production Act
-
The Biden Administration's First 100 Days
-
On the Ballot 2020: Health Care Policy Outlook
-
Key Considerations for Reshoring U.S. Drug Manufacturing
-
Darren Black on The Future of Health Care: Health Care Delivery and Consolidation Trends in 2020 and Beyond
-
Product Launching in the Era of COVID-19
-
Barry Ostrowsky on The Future of Health Care: Health Care Delivery and Consolidation Trends in 2020 and Beyond
-
Holding Pattern: Cannabis Industry Waits for FDA Regulatory Rulemaking
-
COVID-19 Executive Actions, Right-to-Sue Notices, and Liability Shields
-
CA Employer Playbook, Federal COVID-19 Updates, DOL’s FFCRA Rule Vacated in Part
-
Telehealth Flexibility: Key Regulatory Changes Impacting Providers During and Beyond the Coronavirus Pandemic
